TY - JOUR
T1 - Therapeutic vaccination for closed head injury
AU - Kipnis, Jonathan
AU - Nevo, Uri
AU - Panikashvili, David
AU - Alexandrovich, Alexander
AU - Yoles, Eti
AU - Akselrod, Solange
AU - Shohami, Esther
AU - Schwartz, Michal
PY - 2003/6/1
Y1 - 2003/6/1
N2 - Closed head injury often has a devastating outcome, partly because the insult, like other injuries to the central nervous system (CNS), triggers self-destructive processes. During studies of the response to other CNS insults, it was unexpectedly discovered that the immune system, if well controlled, provides protection against self-destructive activities. Here we show that in mice with closed head injury, the immune system plays a key role in the spontaneous recovery. Strain-related differences were observed in the ability to harness a T cell-dependent protective mechanism against the effects of the injury. We further show that the trauma-induced deficit could be reduced, both functionally and anatomically, by post-traumatic vaccination with Cop-1, a synthetic copolymer used to treat patients with multiple sclerosis and found (using a different treatment protocol) to effectively counteract the loss of neurons caused by axonal injury or glutamate-induced toxicity. We suggest that a compound such as Cop-1 can be safely developed as a therapeutic vaccine to boost the body's immune repair mechanisms, thereby providing multifactorial protection against the consequences of brain trauma.
AB - Closed head injury often has a devastating outcome, partly because the insult, like other injuries to the central nervous system (CNS), triggers self-destructive processes. During studies of the response to other CNS insults, it was unexpectedly discovered that the immune system, if well controlled, provides protection against self-destructive activities. Here we show that in mice with closed head injury, the immune system plays a key role in the spontaneous recovery. Strain-related differences were observed in the ability to harness a T cell-dependent protective mechanism against the effects of the injury. We further show that the trauma-induced deficit could be reduced, both functionally and anatomically, by post-traumatic vaccination with Cop-1, a synthetic copolymer used to treat patients with multiple sclerosis and found (using a different treatment protocol) to effectively counteract the loss of neurons caused by axonal injury or glutamate-induced toxicity. We suggest that a compound such as Cop-1 can be safely developed as a therapeutic vaccine to boost the body's immune repair mechanisms, thereby providing multifactorial protection against the consequences of brain trauma.
KW - Autoimmune neuroprotection
KW - Brain injury
KW - CNS inflammation
KW - Cop-1 (Glatiramer acetate)
KW - EAE-susceptibility
KW - Strain differences
UR - http://www.scopus.com/inward/record.url?scp=0038721596&partnerID=8YFLogxK
U2 - 10.1089/089771503767168483
DO - 10.1089/089771503767168483
M3 - Article
C2 - 12906740
AN - SCOPUS:0038721596
SN - 0897-7151
VL - 20
SP - 559
EP - 569
JO - Journal of neurotrauma
JF - Journal of neurotrauma
IS - 6
ER -